STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
62 hedge funds and large institutions have $130M invested in Stemline Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% more funds holding
Funds holding: 61 → 62 (+1)
Holders
62
Holding in Top 10
–
Calls
$264K
Puts
$7K
Top Buyers
| 1 | +$4.87M | |
| 2 | +$3.16M | |
| 3 | +$2.55M | |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$1.09M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$948K |
Top Sellers
| 1 | -$2.12M | |
| 2 | -$1.87M | |
| 3 | -$1.24M | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$679K |